Condition (MeSH)
Ebstein Anomaly
ClinicalTrials.gov lists 4 trials for Ebstein Anomaly or a narrower condition beneath it. National Heart, Lung, and Blood Institute (NHLBI) has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
4 of the 4 trials are tagged with Ebstein Anomaly itself; the rest are tagged with a narrower condition beneath it.
When did Ebstein Anomaly trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2021 | 1 |
| 2016 | 1 |
| 2013 | 1 |
| 2007 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 4 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Ebstein Anomaly trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Observational | 3 |
How many Ebstein Anomaly trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Ebstein Anomaly trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
Which publications cover Ebstein Anomaly? (9)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Fetal Conduction Disease and Arrhythmia in Ebstein's Anomaly and Tricuspid Valve Dysplasia Assessed by Fetal Magnetocardiography. | Journal of the American Heart Association | 2025 | Yes |
| Cone Reconstruction for Ebstein Anomaly: Ventricular Remodeling and Preliminary Impact of Stem Cell Therapy. | Mayo Clinic proceedings | 2021 | Yes |
| Perinatal course of Ebstein's anomaly and tricuspid valve dysplasia in the fetus. | Prenatal diagnosis | 2012 | Yes |
| Mirror syndrome: a systematic review of fetal associated conditions, maternal presentation and perinatal outcome. | Fetal diagnosis and therapy | 2010 | Yes |
| Cerebral vascular resistance and left ventricular myocardial performance in fetuses with Ebstein's anomaly. | American journal of perinatology | 2009 | Yes |
Showing 5 of 9 publications.
Prevalence (66)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Ebstein malformation of the tricuspid valve | Prevalence at birth | 1-9 / 100 000 | United Kingdom | GB | Exact |
| Ebstein malformation of the tricuspid valve | Prevalence at birth | 1-9 / 100 000 | United Kingdom | GB | Exact |
| Ebstein malformation of the tricuspid valve | Prevalence at birth | 1-9 / 100 000 | United Kingdom | GB | Unspecified |
| Ebstein malformation of the tricuspid valve | Prevalence at birth | 1-9 / 100 000 | United States | US | Unspecified |
| Ebstein malformation of the tricuspid valve | Prevalence at birth | 1-9 / 100 000 | United States | US | Exact |
Showing 5 of 66 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Ebstein malformation of the tricuspid valve | 1880 | Exact | Orphadata Science knowledge files, Product 1 |
| Ebstein malformation of the tricuspid valve | 1880 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.